Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Mounjaro, developed by Eli Lilly, is a once-weekly injectable treatment containing the active ingredient tirzepatide, designed to support weight loss. It works by helping you feel fuller for longer and reducing appetite, making it easier to manage food intake. Mounjaro is approved and licensed for weight loss in the US-UK and is available by prescription.
The pack includes:
Each dose (0.6 ml) contains 2.5 mg of tirzepatide.
Mounjaro mimics hormones that naturally occur in the gut after eating, called incretins. Incretins have many functions, such as:
slowing down the emptying of the stomach
sending signals to your brain that you’re full after eating
increasing insulin levels
These combined effects help people feel full after a meal by signalling to the parts of the brain responsible for appetite, making it easier to eat less.
THE ORIGIN OF THIS PRODUCT IS FROM THE United States COMMUNITY
Please read before placing your order.
Orders may be purchased through our website; however, all medications and peptides are subject to review and approval by a qualified healthcare provider. A Good Faith Exam (GFE) is required every 3 months to maintain eligibility and comply with applicable weight-loss program requirements in your area.
The GFE typically takes approximately 15–20 minutes to complete.
Once completed, the medical review and approval process may take up to 1 full business day in some cases.
Completion of a GFE does not guarantee approval. Final approval is determined by the appropriate healthcare provider based on your medical information and applicable requirements.
A new GFE may be required every 3 months to remain active in the program.
Placing an order does not guarantee that you will be approved for treatment.
If you are not approved by the healthcare provider, your payment will be released/refunded within approximately 3–10 business days. The exact timing may vary depending on your bank or payment provider.
Products are dispensed through appropriately licensed 503A and/or 503B pharmacies, as applicable.
Important: Any statement that products are “FDA approved” should be used only where that statement is legally and factually accurate for the specific medication and formulation being provided. FDA approval of an active ingredient or a commercially available product does not necessarily mean that every compounded preparation containing that ingredient is FDA-approved.
This website notice is intended as general program information and does not replace medical advice, a healthcare provider's evaluation, or applicable federal, state, or local requirements.
Mounjaro, developed by Eli Lilly, is a once-weekly injectable treatment containing the active ingredient tirzepatide, designed to support weight loss. It works by helping you feel fuller for longer and reducing appetite, making it easier to manage food intake. Mounjaro is approved and licensed for weight loss in the US-UK and is available by prescription.
The pack includes:
Each dose (0.6 ml) contains 2.5 mg of tirzepatide.
Mounjaro mimics hormones that naturally occur in the gut after eating, called incretins. Incretins have many functions, such as:
slowing down the emptying of the stomach
sending signals to your brain that you’re full after eating
increasing insulin levels
These combined effects help people feel full after a meal by signalling to the parts of the brain responsible for appetite, making it easier to eat less.
THE ORIGIN OF THIS PRODUCT IS FROM THE United States COMMUNITY
Please read before placing your order.
Orders may be purchased through our website; however, all medications and peptides are subject to review and approval by a qualified healthcare provider. A Good Faith Exam (GFE) is required every 3 months to maintain eligibility and comply with applicable weight-loss program requirements in your area.
The GFE typically takes approximately 15–20 minutes to complete.
Once completed, the medical review and approval process may take up to 1 full business day in some cases.
Completion of a GFE does not guarantee approval. Final approval is determined by the appropriate healthcare provider based on your medical information and applicable requirements.
A new GFE may be required every 3 months to remain active in the program.
Placing an order does not guarantee that you will be approved for treatment.
If you are not approved by the healthcare provider, your payment will be released/refunded within approximately 3–10 business days. The exact timing may vary depending on your bank or payment provider.
Products are dispensed through appropriately licensed 503A and/or 503B pharmacies, as applicable.
Important: Any statement that products are “FDA approved” should be used only where that statement is legally and factually accurate for the specific medication and formulation being provided. FDA approval of an active ingredient or a commercially available product does not necessarily mean that every compounded preparation containing that ingredient is FDA-approved.
This website notice is intended as general program information and does not replace medical advice, a healthcare provider's evaluation, or applicable federal, state, or local requirements.
